FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2066580411> ?p ?o ?g. }

• W2066580411 endingPage "4593" @default.
• W2066580411 startingPage "4592" @default.
• W2066580411 abstract "The letter by Hoffman states that Salmonella typhimurium (S. typhimurium) A1-R alone could be equally, or more, efficient in colonizing tumors compared with the VNP20009 strain transformed with short hairpin RNA against indoleamine 2,3-dioxygenase (IDO) described in our recent report in Cancer Research (1). Published evidence highlights the colonizing properties of the A1-R strain that was the result of the unique method for its isolation from mouse tumors (2). As Hoffman states, the A1-R strain has “high tumor colonization efficacy and antitumor efficacy” in a number of xenograft models using immunodeficient mice. These concepts are equally applicable to the VNP20009 strain, as it was also highly regarded for its ability to colonize and eradicate tumors in murine models when administered as a single agent (3). Paradoxically, VNP20009 failed to adequately colonize or control human tumors to the same degree in clinical trials and has since called into question the clinical translation of observations made in syngeneic and xenograft murine models using any S. typhimurium strain (4).Hoffman states that a “direct comparison of tumor-targeting of the IDO-transformed S. typhimurium VNP20009 strain … and S. typhimurium A1-R would be enlightening,” yet will it provide any further insight into mechanisms to attain clinical efficacy? Earlier studies using VNP20009 in patients with metastatic melanoma, even those with evidence of VNP20009 intratumoral colonization, failed to show any signs of regression (4). Thus, while S. typhimurium tumor colonization in murine models correlates with regression, colonization in patient tumors does not. In that sense, the ability of A1-R to efficiently colonize murine tumors may not predict its clinical outcome. In a more recent pilot trial using VNP20009 to express the E. coli cytosine deaminase gene, investigators observed significant conversion of the antifungal agent 5-fluorocytosine to the extremely cytotoxic anticancer agent 5-fluorouracil specifically within patient tumor tissue (5). It is becoming more apparent that S. typhimurium shows more promise as a tumor-specific delivery vehicle than it does as a treatment by itself (6–8). In our study, enhanced colonization of VNP20009 was seen as an additional benefit to silencing IDO. However, the unique ability to attract and activate polymorphonuclear cells strictly within tumor tissue using the combination of VNP20009 and IDO silencing is a novel improvement to S. typhimurium and applicable to many human tumors that express IDO. IDO expression in melanoma could also be interpreted as a possible barrier to VNP20009 efficacy as IDO is known to have antimicrobial activity (9, 10).If a comparison should be made, we feel the more relevant one would be to compare colonization of AR-1 and shIDO-ST in tumors of patients with cancer, and determine whether the property of colonization per se without IDO modulation by shIDO expression correlates with tumor regression. Would AR-1 overcome the barriers that prevented VNP20009 from succeeding as an antitumor therapy? This is a difficult question to answer because it is perplexing why VNP20009 was clinically unsuccessful. It will likely require more than additional observations in murine models showing greater tumor colonization and control by S. typhimurium. More in-depth mechanistic studies of how these S. typhimurium strains achieve tumor growth control would provide a firmer platform for improvement and translation.See the original Letter to the Editor, p. 4591No potential conflicts of interest were disclosed by the authors.This work was partially supported by R01 CA72669 (B.R. Blazar), the Tim Nesvig Lymphoma Research Fund, CIT-COH Biomedical Initiative Grant, and R21-CA174306 (D.J. Diamond). The COH cancer center is supported by 5P30-CA033572-28.The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health." @default.
• W2066580411 created "2016-06-24" @default.
• W2066580411 creator A5054833966 @default.
• W2066580411 creator A5058268746 @default.
• W2066580411 creator A5075582905 @default.
• W2066580411 date "2013-07-15" @default.
• W2066580411 modified "2023-09-23" @default.
• W2066580411 title "Tumor Growth Control with IDO-Silencing <i>Salmonella</i>—Reply" @default.
• W2066580411 cites W1964822107 @default.
• W2066580411 cites W1973123246 @default.
• W2066580411 cites W2000739334 @default.
• W2066580411 cites W2044747539 @default.
• W2066580411 cites W2082013458 @default.
• W2066580411 cites W2115205513 @default.
• W2066580411 cites W2127946912 @default.
• W2066580411 cites W2147011854 @default.
• W2066580411 cites W2151347495 @default.
• W2066580411 cites W4242852378 @default.
• W2066580411 doi "https://doi.org/10.1158/0008-5472.can-13-1274" @default.
• W2066580411 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3804125" @default.
• W2066580411 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23832663" @default.
• W2066580411 hasPublicationYear "2013" @default.
• W2066580411 type Work @default.
• W2066580411 sameAs 2066580411 @default.
• W2066580411 citedByCount "2" @default.
• W2066580411 countsByYear W20665804112014 @default.
• W2066580411 countsByYear W20665804112015 @default.
• W2066580411 crossrefType "journal-article" @default.
• W2066580411 hasAuthorship W2066580411A5054833966 @default.
• W2066580411 hasAuthorship W2066580411A5058268746 @default.
• W2066580411 hasAuthorship W2066580411A5075582905 @default.
• W2066580411 hasBestOaLocation W20665804111 @default.
• W2066580411 hasConcept C104317684 @default.
• W2066580411 hasConcept C119056186 @default.
• W2066580411 hasConcept C121608353 @default.
• W2066580411 hasConcept C126322002 @default.
• W2066580411 hasConcept C2776927270 @default.
• W2066580411 hasConcept C2777658100 @default.
• W2066580411 hasConcept C2778022156 @default.
• W2066580411 hasConcept C2781065037 @default.
• W2066580411 hasConcept C502942594 @default.
• W2066580411 hasConcept C523546767 @default.
• W2066580411 hasConcept C54355233 @default.
• W2066580411 hasConcept C71924100 @default.
• W2066580411 hasConcept C86803240 @default.
• W2066580411 hasConcept C89423630 @default.
• W2066580411 hasConceptScore W2066580411C104317684 @default.
• W2066580411 hasConceptScore W2066580411C119056186 @default.
• W2066580411 hasConceptScore W2066580411C121608353 @default.
• W2066580411 hasConceptScore W2066580411C126322002 @default.
• W2066580411 hasConceptScore W2066580411C2776927270 @default.
• W2066580411 hasConceptScore W2066580411C2777658100 @default.
• W2066580411 hasConceptScore W2066580411C2778022156 @default.
• W2066580411 hasConceptScore W2066580411C2781065037 @default.
• W2066580411 hasConceptScore W2066580411C502942594 @default.
• W2066580411 hasConceptScore W2066580411C523546767 @default.
• W2066580411 hasConceptScore W2066580411C54355233 @default.
• W2066580411 hasConceptScore W2066580411C71924100 @default.
• W2066580411 hasConceptScore W2066580411C86803240 @default.
• W2066580411 hasConceptScore W2066580411C89423630 @default.
• W2066580411 hasIssue "14" @default.
• W2066580411 hasLocation W20665804111 @default.
• W2066580411 hasLocation W20665804112 @default.
• W2066580411 hasLocation W20665804113 @default.
• W2066580411 hasLocation W20665804114 @default.
• W2066580411 hasOpenAccess W2066580411 @default.
• W2066580411 hasPrimaryLocation W20665804111 @default.
• W2066580411 hasRelatedWork W2008952502 @default.
• W2066580411 hasRelatedWork W2099774103 @default.
• W2066580411 hasRelatedWork W2101540258 @default.
• W2066580411 hasRelatedWork W2109763600 @default.
• W2066580411 hasRelatedWork W2509746915 @default.
• W2066580411 hasRelatedWork W2767270188 @default.
• W2066580411 hasRelatedWork W2804249082 @default.
• W2066580411 hasRelatedWork W2977495908 @default.
• W2066580411 hasRelatedWork W3112004363 @default.
• W2066580411 hasRelatedWork W4299364975 @default.
• W2066580411 hasVolume "73" @default.
• W2066580411 isParatext "false" @default.
• W2066580411 isRetracted "false" @default.
• W2066580411 magId "2066580411" @default.
• W2066580411 workType "article" @default.